It has been postulated that del(20)(q), with consistent loss of the EIF6 gene in all cases analysed, imply a good prognosis, with lower risk of MDS/AML and milder haematological conditions [11, 13, 15]. This evidence concerns the gene EIF6 and acute myeloid leukemia.